CARDIOVASCULAR EFFECTS PRODUCED BY MICROINJECTION of ANGIOTENSIN-(1-7) ON VASOPRESSOR and VASODEPRESSOR SITES of the VENTROLATERAL MEDULLA
dc.contributor.author | Silva, LCS | |
dc.contributor.author | Fontes, MAP | |
dc.contributor.author | Campagnolesantos, M. J. | |
dc.contributor.author | Khosla, M. C. | |
dc.contributor.author | Campos, R. R. | |
dc.contributor.author | Guertzenstein, P. G. | |
dc.contributor.author | Santos, RAS | |
dc.contributor.institution | Universidade Federal de Minas Gerais (UFMG) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | CLEVELAND CLIN EDUC FDN | |
dc.date.accessioned | 2016-01-24T11:40:13Z | |
dc.date.available | 2016-01-24T11:40:13Z | |
dc.date.issued | 1993-06-11 | |
dc.description.abstract | In this study, we determined the cardiovascular effects produced by micro-injection of the heptapeptide Angiotensin-(1-7) [Ang-(1-7)] into the rat ventrolateral medulla (VLM). Micro-injection of Ang-(1-7) into the rostral VLM and the caudal pressor area of the VLM produced significant increases in arterial pressure, comparable to that observed with micro-injection of Ang II. the changes in arterial pressure were associated with more variable changes in heart rate (HR) (usually tachycardia). On the other hand, micro-injection of Ang-(1-7) into the caudal depressor area induced decreases in arterial pressure and HR. the results suggest that, besides Ang II, Ang-(1-7) is involved in the mediation of the cardiovascular actions of the renin-angiotensin system in the VLM. | en |
dc.description.affiliation | UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT FISIOL & BIOFIS,HIPERTENSAO LAB,BR-31270 BELO HORIZON,MG,BRAZIL | |
dc.description.affiliation | ESCOLA PAULISTA MED,DEPT FISIOL,BR-04023 São Paulo,BRAZIL | |
dc.description.affiliation | CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106 | |
dc.description.affiliationUnifesp | ESCOLA PAULISTA MED,DEPT FISIOL,BR-04023 São Paulo,BRAZIL | |
dc.description.source | Web of Science | |
dc.format.extent | 321-325 | |
dc.identifier | http://dx.doi.org/10.1016/0006-8993(93)90920-I | |
dc.identifier.citation | Brain Research. Amsterdam: Elsevier B.V., v. 613, n. 2, p. 321-325, 1993. | |
dc.identifier.doi | 10.1016/0006-8993(93)90920-I | |
dc.identifier.issn | 0006-8993 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/25334 | |
dc.identifier.wos | WOS:A1993LH29300023 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Brain Research | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.subject | VENTROLATERAL MEDULLA | en |
dc.subject | ANGIOTENSIN-II | en |
dc.subject | ANGIOTENSIN-(1-7) | en |
dc.subject | VASOMOTOR ACTIVITY | en |
dc.title | CARDIOVASCULAR EFFECTS PRODUCED BY MICROINJECTION of ANGIOTENSIN-(1-7) ON VASOPRESSOR and VASODEPRESSOR SITES of the VENTROLATERAL MEDULLA | en |
dc.type | info:eu-repo/semantics/article |